Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Paying user area

Try for free

Vertex Pharmaceuticals Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Vertex Pharmaceuticals Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

		Jun 30, 2025		Mar 31, 2025		Dec 31, 2024		Sep 30, 2024		Jun 30, 2024		Mar 31, 2024		Dec 31, 2023		Sep 30, 2023		Jun 30, 2023		Mar 31, 2023		Dec 31, 2022		Sep 30, 2022		Jun 30, 2022		Mar 31, 2022		Dec 31, 2021		Sep 30, 2021		Jun 30, 2021		Mar 31, 2021		Dec 31, 2020		Sep 30, 2020		Jun 30, 2020		Mar 31, 2020
	Cash and cash equivalents
	Marketable securities
	Accounts receivable, net
	Inventories
	Prepaid expenses and other current assets
	Current assets
	Property and equipment, net
	Goodwill
	Other intangible assets, net
	Deferred tax assets
	Operating lease assets
	Long-term marketable securities
	Other assets
	Long-term assets
	Total assets

Cash and cash equivalents: Cash and cash equivalents showed an overall upward trend from the beginning of the period through December 2022, peaking at approximately $10.5 billion. However, from early 2023 onward, a downward trend was observed with fluctuations, declining to around $4.7 billion by March 2025. The notable decline after December 2022 suggests increased cash outflows or investments during that time frame.
Marketable securities: Marketable securities demonstrated moderate volatility across the quarters. Early data shows fluctuations under $800 million with a decrease in late 2022 to $274.5 million. Beginning in 2023, values improved, reaching a peak of $1.54 billion by March 2025, indicating a stronger allocation to liquid investments over time.
Accounts receivable, net: Accounts receivable exhibited a steady increase throughout the entire period, rising from approximately $845 million to over $1.8 billion by March 2025. This growth suggests increasing sales on credit or a lengthening of receivable collection periods.
Inventories: Inventories demonstrated consistent growth, more than doubling between March 2020 and December 2023, and continuing an upward trajectory to nearly $1.5 billion by March 2025. This consistent increase may reflect stockpiling, expansion, or altered inventory management practices.
Prepaid expenses and other current assets: This category experienced variability, initially increasing significantly in mid-2021 before fluctuating in subsequent quarters. There was no clear long-term trend, with values moving between approximately $220 million and $665 million, suggesting variable payments or asset recognition timing.
Current assets: Overall, current assets increased steadily from about $5.4 billion to a peak near $14.7 billion in late 2023, followed by a decline to approximately $10.4 billion by June 2025. The decline after the peak aligns with decreasing cash and equivalents, reflecting changes in liquidity management or operational expenditures.
Property and equipment, net: Property and equipment demonstrated gradual growth from around $736 million to approximately $1.3 billion, indicating ongoing capital investment and asset acquisition over the period.
Goodwill: Goodwill remained relatively stable at roughly $1 billion until late 2021, when an increase to about $1.08 billion was recorded, after which values remained constant, suggesting no major impairment or acquisition activity affecting goodwill value.
Other intangible assets, net: Other intangible assets were steady at $400 million until a notable increase occurred late 2021 to early 2022, peaking at $839.9 million in late 2023, followed by a sharp decline to roughly $435 million by mid-2025. These fluctuations could reflect asset revaluation, amortization, or impairment.
Deferred tax assets: Deferred tax assets consistently increased from approximately $1.15 billion to $2.7 billion, reflecting growing tax-related benefits or timing differences in income recognition.
Operating lease assets: Operating lease assets appeared from late 2020 onward, initially stable around $310-$330 million, followed by a sharp increase in 2024 exceeding $1.3 billion before slightly declining. This pattern may indicate new lease agreements or accounting changes related to leasing.
Long-term marketable securities: Long-term marketable securities first recorded in late 2022 showed rapid growth from $112.2 million to over $5.6 billion by mid-2025, signaling significant long-term investment increases.
Other assets: Other assets increased from $160 million to over $1 million, with some fluctuation. Notably, significant growth occurred between 2022 and 2023, which may reflect increased intangible or miscellaneous asset recognition.
Long-term assets: Long-term assets rose steadily from approximately $3.4 billion to a maximum near $13.6 billion by mid-2025, indicating substantial investment in fixed and intangible assets over the period.
Total assets: Total assets exhibited continuous growth from about $8.9 billion to a peak of approximately $24.0 billion in mid-2025, reflecting overall asset expansion driven by both current and long-term asset increases, despite some volatility in certain categories.

Assets: Selected Items

Download chart

Current Assets: Selected Items